Project Grant HT94252310889
Award Date 9/15/23
Completion Date 9/14/26
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
- This Project Grant award, totaling $2,685,519.00, was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cedars-Sinai Medical Center in West Hollywood, CA. The grant supports advanced biomedical research to define human correlates of super-evasive disseminated tumor cells, assess their pathological relevance, and explore methods to eradicate them. This 4-year research project, running from July 1, 2025 to June 30, 2029, aims to...
- The U.S. Department of Defense awarded a $1,000,000.00 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420) to evaluate short- and long-term systemic anti-tumor immunity following combined radiation and immunotherapy in triple-negative breast cancer. This 4-year research project, which commenced on Sep 15, 2023 and is scheduled for completion by Sep 14, 2027, aims to investigate medical solutions for transforming healthcare for...
- This Project Grant award of $1,252,479.00 from the Defense Health Agency supports Cedars-Sinai Medical Center's biomedical research to re-engineer the intratumoral myeloid-macrophage compartment and enhance the response to radiation and immunotherapy in triple-negative breast cancer. The award falls under the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for Service Members and the public through innovative and impactful research....
- This $1,251,673.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cedars-Sinai Medical Center on August 1, 2023. The grant will fund research aimed at re-engineering the intratumoral myeloid-macrophage compartment to enhance the response to radiation and immunotherapy in triple-negative breast cancer. The three-year project will be performed at Cedars-Sinai's facilities in West Hollywood, CA. As a leading...
- The Defense Health Agency awarded a $598,130 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. Specifically, the project will investigate the "Determinants of Lung Cancer-Associated Cachexia" over the period from February 15, 2025 to February 14, 2027. As a leading research...
- This $729,690 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports metabolic intervention research to halt pancreatic cancer at Cedars-Sinai Medical Center in West Hollywood, California. The project will run from November 1, 2024 to October 31, 2027, investigating innovative approaches to disease prevention, diagnosis, treatment, and management of pancreatic cancer. As a prominent research institution,...
- The Department of the Army Medical Command awarded Cedars-Sinai Medical Center a $601,684 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on Novel DZ-Artemisinin for Treatment of Pancreatic Cancer. The three-year award beginning August 15, 2022 will fund the development of an innovative therapy using DZ-Artemisinin derivatives to treat pancreatic cancer at Cedars-Sinai's facilities located in West Hollywood, California. The Military...
- The U.S. Department of Defense (DoD) has awarded a $3,056,435 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420) to conduct a 4-year evaluation of short- and long-term systemic anti-tumor immunity following combined radiation and immunotherapy treatments in triple-negative breast cancer. The award, effective September 15, 2023, will support the medical center's biomedical research efforts to investigate novel therapeutic...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $501,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 15, 2025, with a completion date of July 14, 2027. The research project, titled "Large Oncosomes as Drivers of Prostate Cancer Bone Metastasis," is being conducted at the institution's West Hollywood, California location. This award supports biomedical...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $600,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2026, through April 30, 2030. The award funds research titled "FROM H & E TO HRD: LINKING MORPHOMETRY, CLINICAL, AND MOLECULAR DATA FOR DRUG RESPONSE PREDICTION," which will be conducted at the institution's West Hollywood, California location. This project...